Syros Pharmaceuticals Inc SYRS
Morningstar Growth Grade = A
Projected Annual Return = 18.6%
June 23, 2021 price = $5.28
Company Profile
Business Description
Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology and other related markets that address gene control and cancer. The Company operates only in the United States.
SectorHealthcare
IndustryBiotechnology
Most Recent EarningsMar 31, 2021
Fiscal Year EndDec 31, 2020
No comments:
Post a Comment